Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Lymphoma, Mantle-Cell × Rituximab × Clear all

Phase

Phase 2 117 Phase 1/2 40 Phase 1 31 Phase 3 28 Phase NA 3 Phase EARLY_PHASE1 3 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Lymphoma, Non-Hodgkin 5 Leukemia, Lymphocytic, Chronic, B-Cell 4 Neoplasms 2 Lymphoma, B-Cell, Marginal Zone 2 Arthritis, Rheumatoid 2 Waldenstrom Macroglobulinemia 1 Sjogren's Syndrome 1 Neoplasm, Residual 1 Mediastinal Neoplasms 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Lymphohistiocytosis, Hemophagocytic 1 Lymphatic Diseases 1 Leukemia, B-Cell 1 Leukemia 1 Heart Failure 1 Epstein-Barr Virus Infections 1 Burkitt Lymphoma 1

Interventions

Cyclophosphamide 2 temsirolimus 1 prednylidene 1 ibrutinib 1 acalabrutinib 1 Vincristine 1 Thiotepa 1 Thalidomide 1 Rituximab 1 Radiotherapy 1 Prednisone 1 Filgrastim 1 Etoposide 1 Doxorubicin 1 Dexamethasone 1 Cytarabine 1 Cisplatin 1 Antilymphocyte Serum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02858804 2026-02-11

BDH-MCL01

Institute of Hematology & Blood Diseases Hospital, China

Phase 4 Completed

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡